Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Clinical Therapeutics|June 6, 2025
Characteristics and Treatment Patterns of People Without Type 2 Diabetes Diagnoses Who Use Tirzepatide in the United StatesTheresa Hunter Gibble, Emily R Hankosky, Alexandra Meeks, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 28, 2022
An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report RecommendationsJay P Bae, Zbigniew A Kadziola, Dongju Liu, et al.Journal of Pharmaceutical Policy and Practice|September 8, 2017
Evaluation of a guided continuous quality improvement program in community pharmaciesChanadda Chinthammit, Michael T Rupp, Edward P Armstrong, et al.Journal of Managed Care & Specialty Pharmacy|March 1, 2019
Retrospective Review of Exceptions for Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Recommendations for a Diabetic Medicare PopulationChanadda Chinthammit, Amanda Harrington, Ann Wild, et al.Diabetes, Obesity & Metabolism|February 25, 2025
Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity databaseEmily R Hankosky, Chanadda Chinthammit, Alexandra Meeks, et al.Journal of the American Heart Association|August 27, 2020
Associations of Renin-Angiotensin System Antagonist Medication Adherence and Economic Outcomes Among Commercially Insured US Adults: A Retrospective Cohort StudyPatrick J Campbell, David R Axon, Ann M Taylor, et al.Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.Journal of the American Pharmacists Association : Japha|May 12, 2020
Exploring performance predictors among employees in a pharmacist-led medication management centerSrujitha Marupuru, David R Axon, Patrick Campbell, et al.Journal of Managed Care & Specialty Pharmacy|March 1, 2021
Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United StatesSanjay Bajpai, Siew Wong-Jacobson, Dongju Liu, et al.Journal of Managed Care & Specialty Pharmacy|December 30, 2020
Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort studyChanadda Chinthammit, David R Axon, Lea Mollon, et al.Pageof 3